SCHEMBL3621623

SCHEMBL3621623

CC#CCOc1ccc2cc(CO)oc2c1

nearest known ligand 0.48

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
MTNR1A P48039 1/20 0.48
CYP19A1 P11511 8/20 0.46
CYP2C19 P33261 2/20 0.46
CYP3A4 P08684 1/20 0.46
CYP2C9 P11712 1/20 0.46
CYP1A2 P05177 2/20 0.44
HDAC6 Q9UBN7 1/20 0.43
MAOA P21397 1/20 0.42
MAOB P27338 1/20 0.42
CA12 O43570 5/20 0.42
CA9 Q16790 5/20 0.42
CA4 P22748 4/20 0.42
CA1 P00915 3/20 0.42
GLA P06280 1/20 0.39
CA6 P23280 1/20 0.38
CA5A P35218 1/20 0.38
CA7 P43166 1/20 0.38
CA14 Q9ULX7 1/20 0.38
CA5B Q9Y2D0 1/20 0.38
NPC1 O15118 2/20 0.38

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL3621561 0.86 MTNR1A (0.48) MTNR1ACYP19A1CYP2C19CYP3A4CYP2C9
SCHEMBL7289069 0.77 ALDH1A1 (0.53) CYP2C19HDAC6MAOBCA12CA9
7-(2-Butynyloxy)Coumarin SCHEMBL17682923 0.77 MTNR1A (0.77) MTNR1ACYP1A2MAOAMAOBCA12
SCHEMBL3619696 0.76 MTNR1A (0.45) MTNR1ACYP19A1CYP2C19CYP3A4CYP2C9
SCHEMBL3619684 0.75 SLC2A1 (0.56) MTNR1ACYP19A1CYP2C19CYP3A4CYP2C9
SCHEMBL3617868 0.73 MAOB (0.62) MTNR1AMAOAMAOBCA12CA9
SCHEMBL3618379 0.73 NPC1 (0.40) MTNR1ACYP19A1CYP2C19CYP3A4CYP2C9
SCHEMBL14364687 0.72 MAOB (0.52) MTNR1ACYP3A4CYP1A2HDAC6MAOA
SCHEMBL3619676 0.72 CYP19A1 (0.42) MTNR1ACYP19A1CYP2C19CYP3A4CYP2C9
SCHEMBL3615496 0.71 LTA4H (0.47) MTNR1ACYP19A1HDAC6MAOAMAOB

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 8 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7829585-B2 Antifungal agent containing pyridine derivative EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-11-09 US disclosed
US-7829585-B2 Antifungal agent containing pyridine derivative EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-11-09 US disclosed
US-7829585-B2 Antifungal agent containing pyridine derivative EISAI R&D MANAGEMENT CO., LTD. (JP) 2010-11-09 US disclosed
US-20090062348-A1 Antifungal Agent Containing Pyridine Derivative EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-03-05 US disclosed
US-20090062348-A1 Antifungal Agent Containing Pyridine Derivative EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-03-05 US disclosed
US-20090062348-A1 Antifungal Agent Containing Pyridine Derivative EISAI R&D MANAGEMENT CO., LTD. (JP) 2009-03-05 US disclosed
EP-1864980-A1 ANTIFUNGAL AGENT CONTAINING PYRIDINE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2007-12-12 EP disclosed
EP-1864980-A1 ANTIFUNGAL AGENT CONTAINING PYRIDINE DERIVATIVE Eisai R&D Management Co., Ltd. (JP) 2007-12-12 EP disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20090062348-A1 Antifungal Agent Containing Pyridine Derivative ERG28, SQOR, CYP51A1 MTNR1A 632/4885CYP19A1 459/4885CYP2C19 5/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.